Breaking News Instant updates and real-time market news.

AAPL

Apple

$162.71

6.3 (4.03%)

, BAC

Bank of America

$31.12

0.79 (2.60%)

08:55
02/13/18
02/13
08:55
02/13/18
08:55

Notable open interest changes for February 13th

Monday's total option volume of 22.7 million contracts resulted in net open interest growth of 4.37 million calls and 2.64 million puts. Apple (AAPL), Bank of America (BAC), AMD (AMD) and Facebook (FB) saw the greatest growth. Top five new positions opened include 35k AMD (AMD) Mar-18 13 calls, 35k AMD (AMD) Mar-18 13 puts, 31k Apple (AAPL) Mar-18 155 puts, 30k Apple (AAPL) Mar-18 155 calls and 24k Microsoft (MSFT) Mar-18 60 puts.

AAPL

Apple

$162.71

6.3 (4.03%)

BAC

Bank of America

$31.12

0.79 (2.60%)

AMD

AMD

$11.68

0.37 (3.27%)

FB

Facebook

$176.41

0.3 (0.17%)

  • 13

    Feb

  • 13

    Feb

  • 15

    Feb

  • 23

    Feb

  • 28

    Feb

  • 07

    Mar

AAPL Apple
$162.71

6.3 (4.03%)

02/06/18
MKMP
02/06/18
NO CHANGE
Target $54
MKMP
Buy
Cirrus Logic price target lowered to $54 from $74 at MKM Partners
MKM Partners analyst Ruben Roy lowered his price target on Cirrus Logic (CRUS) to $54 after a Q3 earnings miss attributed to unexpected weakness in smartphone demand that began to materialize in late December. Roy also notes the Q4 outlook well below consensus, suggesting that the handset demand remains weak. The analyst keeps his Buy rating on Cirrus Logic longer term however, based on the company's ability to benefit from content gain opportunities at Apple (AAPL) and new design opportunities at Android manufacturers as well as ongoing proliferation of audio and voice technologies.
02/08/18
BERN
02/08/18
NO CHANGE
Target $125
BERN
Market Perform
NXP Semiconductors results likely to bring Qualcomm deal price to a head, says Bernstein
Bernstein analyst Stacy Rasgon notes that NXP Semiconductors' (NXPI) Q4 results were "very strong," and wonders a bit how much upside might have been Apple (AAPL)-related given SCD and SII dynamics given obvious weakness in the latter's supply chain. The analyst believes NXP Semiconductors' strong results are likely to bring the Qualcomm (QCOM) deal price to a head, but could also make it easier for management to justify a higher price, and it does not appear challenging to justify higher levels even with the shares at a discount to the industry. Rasgon reiterates a Market Perform rating and $125 price target on NXP Semiconductors' shares.
02/08/18
BOFA
02/08/18
NO CHANGE
Target $220
BOFA
Buy
Apple 'a name to own' in volatile markets, says BofA/Merrill
BofA Merrill Lynch analyst Wamsi Mohan calls Apple "a name to own" in times of market volatility, citing its low leverage, high cash balance, attractive valuation and opportunities for future growth. The analyst, who already models a 10% dividend increase in 2018 and expects Apple to announce a new authorization in the April timeframe that could be higher than its typical annual $30B-$50B, reiterates a Buy rating and $220 price target on Apple shares.
02/12/18
WELS
02/12/18
NO CHANGE
Target $195
WELS
Market Perform
Apple iPhone X was highest selling model, says Wells Fargo
Wells Fargo analyst Aaron Rakers notes that IDC has published its detailed estimates for smartphone shipments for the December quarter. The analyst thinks it is important to point out that, like Apple, IDC reports shipments on a sell-in less basis, with iPhone X shipments in the December quarter at 26.9M, which accounts for 35% of total shipments in Q4. Despite less than a full quarter of availability, iPhone X was the highest selling model in the September and December quarters, accounting for 22% of total shipments, he adds. Rakers reiterates a Market Perform rating and $195 price target on the shares.
BAC Bank of America
$31.12

0.79 (2.60%)

01/18/18
BMOC
01/18/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America price target raised to $34 from $31 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Bank of America to $34 despite its "expense-driven" miss on Q4 earnings. Fotheringham says he remains bullish on banks based on the "indirect benefits of tax reform", while keeping his Market Perform rating on Bank of America given its two-year forward PE valuation trading around long-term historical average.
01/18/18
RBCM
01/18/18
NO CHANGE
Target $35
RBCM
Outperform
Bank of America price target raised to $35 from $30 at RBC Capital
RBC Capital analyst Gerard Cassidy raised his price target on Bank of America to $35, citing a "strong all around performance" in Q4 along with the bank's commitment to keeping a low expense and growing top line profile. Cassidy says the bank remains "rate sensitive" and expects some $3.3B in net interest income from a 100bps move in short term rates. The analyst also keeps his Outperform rating on Bank of America, pointing to a positive impact from a stronger U.S. economy on its businesses, along with the return of excess capital, supporting a higher stock price view.
01/31/18
DBAB
01/31/18
NO CHANGE
Target $15
DBAB
Sell
GE likely to be dropped from Dow 30 index, says Deutsche Bank
General Electric (GE) is likely to be dropped from the Dow Jones Industrial Average after being in the index of 30 companies for over 110 years as an original member since 1896, Deutsche Bank analyst John Inch tells investors in a research note. The chances that GE could be removed from the Dow are increasing as the company continues to face "substantial challenges," the analyst writes. These include "earnings and cash pressure, tough global power generation markets, aggressive downsizing, shrinking its portfolio, management shake-up and SEC investigations," Inch argues. He sees "headline risk" as the most significant risk factor if GE were to be dropped from the Dow, "potentially amplified by GE's high mix of retail investors." Inch notes that the last major Dow shakeup occurred in September 2003, when American Airlines (AAL), Bank of America (BAC) and Hewlett Packard (HPQ) were removed and Goldman Sachs (GS), Nike (NKE) and Verizon (VZ) were added. Inch has a Sell rating on General Electric with a $15 price target. The shares closed yesterday down 33c to $15.95.
02/02/18
MSCO
02/02/18
NO CHANGE
MSCO
BofA, JPMorgan, Citi best positioned for tougher CCAR test, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck said she had expected an easier stress test from the Federal Reserve but that the 2018 CCAR test actually seems tougher than last year, given the more intense recessions and lower asset prices modeled in it. A tougher test makes her less optimistic on her strong payout growth expectations, said Graseck, who sees Bank of America (BAC), JPMorgan (JPM) and Citi (C) as best positioned to "weather the storm" and increase payouts given their resilient balance sheets and significant excess capital. She sees Goldman Sachs (GS), which recently cut buybacks, as at risk from a tougher test, which likely weighs on the bank's 2018 ask, Graseck added.
AMD AMD
$11.68

0.37 (3.27%)

02/01/18
02/01/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. eBay (EBAY) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mark Mahaney citing the "ongoing acceleration in Marketplace gross merchandise volume, the surprise announcement that eBay will intermediate payments, and materially ramped up share repurchases." 2. Textron (TXT) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Rajeev Lalwani citing the growing chances he sees of a bizjet recovery, the stock's relative underperformance over the last year and upside levers that include R&D cuts, M&A, or more capital returns. 3. Invesco (IVZ) upgraded to Outperform from Neutral at Credit Suisse with analyst Craig Siegenthaler saying the operating expense reset with yesterday's fourth quarter results, recent sell-side downgrades, and share price underperformance over the last six months presents an upgrade opportunity and attractive valuation. 4. Baker Hughes (BHGE) upgraded to Neutral from Sell at Goldman Sachs with analyst Waqar Syed saying he believes expectations have been reset lower over the last six months and highlights his firm's more favorable commodity price outlook. 5. AMD (AMD) upgraded to Buy from Hold at Argus with analyst Jim Kelleher saying the latest quarterly results demonstrate the "sustainability of the company's return to consistent profitability and top and bottom-line growth." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/01/18
ARGS
02/01/18
UPGRADE
Target $18
ARGS
Buy
AMD upgraded to Buy at Argus on more consistent profitability
As reported earlier, Argus analyst Jim Kelleher upgraded AMD to Buy from Hold with an $18 price target. Kelleher says the latest quarterly results demonstrate the "sustainability of the company's return to consistent profitability and top and bottom-line growth". The analyst adds that AMD can increase its new and existing business despite the margins not being "industry competitive" yet. Kelleher further cites the management's expectations of average selling price "trends to improve based on growing OEM demand for higher-performance Ryzen 5 and Ryzen 7 chips".
02/01/18
ARGS
02/01/18
UPGRADE
ARGS
Buy
AMD upgraded to Buy from Hold at Argus
01/31/18
MSCO
01/31/18
NO CHANGE
Target $8
MSCO
Underweight
AMD earnings potential doesn't justify stock price, says Morgan Stanley
Morgan Stanley analyst Joseph Moore said Ethereum's 300% move since October should continue to drive strong mining revenues at AMD while its core CPU business has significant growth potential. However, he still struggles to see enough earnings potential to justify upside to the stock at current levels, as his CY18 EPS estimate was lowered by 4c to 31c and he cut his CY19 estimate, also to 31c, contending that the drag from higher opex and tax rate more than offsets the benefit from higher sales. Moore keeps an Underweight rating with an $8 price target on AMD shares.
FB Facebook
$176.41

0.3 (0.17%)

02/12/18
BMOC
02/12/18
NO CHANGE
Target $28
BMOC
Market Perform
Twitter price target raised to $28 from $22 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Twitter (TWTR) to $28 after Q1 results, saying the company has a "clearer strategy" to sustain its revenue momentum thanks to video and AI helping grow mainstream adoption. As top-line pressures fade, writes the analyst in his research note titled "Solid Steps Down Road to Recovery", the stock could become "more interesting", though he is also weary of Facebook (FB) competition still "looming large". Salmon keeps a Market Perform rating on Twitter.
02/02/18
ARGS
02/02/18
NO CHANGE
Target $237
ARGS
Buy
Facebook price target raised to $237 from $215 at Argus
Argus analyst Joseph Bonner raised his price target on Facebook to $237 and kept his Buy rating after Q4 earnings. Bonner contends that while the management decision to enhance user interaction contributed to a 5% decline in time spent on the site in the short term, the value of time spent may actually increase with higher advertising rates as user engagement becomes more relevant. The analyst also believes that Facebook is well positioned to capture the shift of audiences and advertisers to mobile digital video.
02/01/18
RBCM
02/01/18
NO CHANGE
Target $250
RBCM
Outperform
Facebook price target raised to $250 from $230 at RBC Capital
RBC Capital analyst Mark Mahaney raised his price target on Facebook to $250 and kept his Outperform rating after a "very strong" Q4. Mahaney says the company's growth trends remained "very impressive" and also cites the management's expectations that News Feed changes promoting "meaningful interaction" will not have a negative impact on advertising revenue growth - a notion with which he agrees.
02/01/18
MZHO
02/01/18
NO CHANGE
Target $250
MZHO
Buy
Facebook price target raised to $250 from $230 at Mizuho
Mizuho analyst James Lee raised his price target for Facebook to $250 from $230, citing a "strong finish" to 2017 and implying ARPU at $28 in 2019, which he believes still has a lot of room to grow based the company's optionality. Lee reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

TWX

Time Warner

$98.91

(0.00%)

, CMCSA

Comcast

$33.85

0.03 (0.09%)

16:58
06/17/18
06/17
16:58
06/17/18
16:58
Hot Stocks
Box Office Battle: 'Incredibles 2' breaks record with $180M »

Disney (DIS) and…

TWX

Time Warner

$98.91

(0.00%)

CMCSA

Comcast

$33.85

0.03 (0.09%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$49.11

-0.02 (-0.04%)

FOX

21st Century Fox

$44.57

0.14 (0.32%)

FOXA

21st Century Fox

$44.60

0.03 (0.07%)

LGF.A

Lionsgate

$26.57

1.52 (6.07%)

DIS

Disney

$108.91

0.15 (0.14%)

VIAB

Viacom

$29.40

0.49 (1.69%)

VIA

Viacom

$33.95

0.15 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

OAS

Oasis Petroleum

$12.01

-0.63 (-4.98%)

, OMP

Oasis Midstream Partners

$17.29

-1.02 (-5.57%)

16:46
06/17/18
06/17
16:46
06/17/18
16:46
Conference/Events
JPMorgan to hold a conference »

3rd Annual Energy Equity…

OAS

Oasis Petroleum

$12.01

-0.63 (-4.98%)

OMP

Oasis Midstream Partners

$17.29

-1.02 (-5.57%)

SRCE

1st Source

$55.36

0.13 (0.24%)

LGCY

Legacy Reserves

$6.07

-0.03 (-0.49%)

EVA

Enviva

$29.35

0.15 (0.51%)

CRC

California Resources

$35.03

-2.57 (-6.84%)

INSM

Insmed

$26.74

-1.5 (-5.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 28

    Sep

16:43
06/17/18
06/17
16:43
06/17/18
16:43
Conference/Events
Leerink to hold a tour »

Ribs N' Bones Bus…

16:40
06/17/18
06/17
16:40
06/17/18
16:40
Conference/Events
Citigroup to hold a conference »

2018 European Healthcare…

GM

General Motors

$43.91

0.32 (0.73%)

, FCAU

Fiat Chrysler

$20.86

-0.37 (-1.74%)

16:38
06/17/18
06/17
16:38
06/17/18
16:38
Periodicals
Automakers putting smaller engines into big trucks, WSJ reportsFord »

U.S. auto makers are…

GM

General Motors

$43.91

0.32 (0.73%)

FCAU

Fiat Chrysler

$20.86

-0.37 (-1.74%)

F

Ford

$11.88

-0.01 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

MSFT

Microsoft

$100.24

-1.14 (-1.12%)

, GOOGL

Alphabet Class A

$1,159.03

-1.08 (-0.09%)

16:34
06/17/18
06/17
16:34
06/17/18
16:34
Periodicals
Microsoft is fixing office, WSJ reports »

The new version of…

MSFT

Microsoft

$100.24

-1.14 (-1.12%)

GOOGL

Alphabet Class A

$1,159.03

-1.08 (-0.09%)

GOOG

Alphabet

$1,151.95

-0.05 (-0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 28

    Oct

16:34
06/17/18
06/17
16:34
06/17/18
16:34
Conference/Events
Deutsche Bank to hold a conference »

Taiwan Auto Electronics…

WFC

Wells Fargo

$54.99

0.23 (0.42%)

, MS

Morgan Stanley

$51.17

-0.12 (-0.23%)

16:33
06/17/18
06/17
16:33
06/17/18
16:33
Conference/Events
Federal Reserve Bank of New York to hold a conference »

Reforming Culture &…

WFC

Wells Fargo

$54.99

0.23 (0.42%)

MS

Morgan Stanley

$51.17

-0.12 (-0.23%)

BAC

Bank of America

$29.27

-0.24 (-0.81%)

C

Citi

$66.34

0.18 (0.27%)

WBK

Westpac Banking

$20.67

0.125 (0.61%)

GS

Goldman Sachs

$232.00

-1.695 (-0.73%)

BCS

Barclays

$10.59

-0.225 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 19

    Jun

  • 21

    Jun

  • 22

    Jun

  • 13

    Jul

  • 10

    Sep

  • 14

    Jan

  • 12

    Apr

  • 15

    Apr

  • 13

    Jul

  • 16

    Jul

  • 15

    Oct

  • 15

    Oct

F

Ford

$11.88

-0.01 (-0.08%)

16:25
06/17/18
06/17
16:25
06/17/18
16:25
Hot Stocks
Ford acquires Michigan Central Station »

Ford Motor has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$54.81

1.165 (2.17%)

16:22
06/17/18
06/17
16:22
06/17/18
16:22
Hot Stocks
Bristol-Myers' ELOQUENT-3 trial meets primary endpoint »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 10

    Jul

PTCT

PTC Therapeutics

$37.57

-0.75 (-1.96%)

, RHHBY

Roche

$0.00

(0.00%)

16:18
06/17/18
06/17
16:18
06/17/18
16:18
Hot Stocks
PTC Therapeutics presents updated preliminary data from SMA FIREFISH Program »

PTC Therapeutics (PTCT)…

PTCT

PTC Therapeutics

$37.57

-0.75 (-1.96%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTK

Cytokinetics

$9.95

0.5 (5.29%)

16:15
06/17/18
06/17
16:15
06/17/18
16:15
Hot Stocks
Cytokinetics announces data from Phase 2 clinical study of Reldesemtiv in SMA »

Cytokinetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PERY

Perry Ellis

$27.92

0.31 (1.12%)

16:12
06/17/18
06/17
16:12
06/17/18
16:12
Hot Stocks
Perry Ellis enters into $437M transaction to become private company »

Perry Ellis International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSTM

Verastem

$6.53

0.95 (17.03%)

16:08
06/17/18
06/17
16:08
06/17/18
16:08
Hot Stocks
Verastem presents duvelisib data at EHA 2018 annual meeting »

Verastem announced one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Oct

IQ

iQIYI

$40.16

-0.44 (-1.08%)

16:05
06/17/18
06/17
16:05
06/17/18
16:05
Hot Stocks
iQIYI obtains broadcasting rights for all four golf majors »

iQIYI announced it had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$200.55

0.86 (0.43%)

15:56
06/17/18
06/17
15:56
06/17/18
15:56
Conference/Events
Home Depot participates in a field trip with UBS »

Field Trip to Atlanta, GA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAY

Verifone

$22.84

0.01 (0.04%)

15:28
06/17/18
06/17
15:28
06/17/18
15:28
Conference/Events
Verifone to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CACI

CACI

$167.60

1.1 (0.66%)

14:18
06/17/18
06/17
14:18
06/17/18
14:18
Conference/Events
CACI to hold a webcast »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

ARGX

Argenx

$92.38

-3.32 (-3.47%)

14:11
06/17/18
06/17
14:11
06/17/18
14:11
Conference/Events
Argenx to hold a KOL breakfast symposium »

Management holds a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

PTC

PTC

$94.87

-0.46 (-0.48%)

14:06
06/17/18
06/17
14:06
06/17/18
14:06
Conference/Events
PTC to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:41
06/17/18
06/17
13:41
06/17/18
13:41
Conference/Events
Federal Reserve Bank of Atlanta president speaks at a meeting »

Atlanta Federal Reserve…

VRX

Valeant

$26.86

0.06 (0.22%)

13:31
06/17/18
06/17
13:31
06/17/18
13:31
Conference/Events
Breaking Conference/Events news story on Valeant »

FDA PDUFA Date for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 27

    Aug

WMGI

Wright Medical

$25.83

-0.26 (-1.00%)

13:27
06/17/18
06/17
13:27
06/17/18
13:27
Conference/Events
Wright Medical management to meet with Leerink »

Meeting to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

XLRN

Acceleron

$36.04

-0.08 (-0.22%)

, ARQL

ArQule

$5.00

-0.31 (-5.84%)

04:55
06/17/18
06/17
04:55
06/17/18
04:55
Conference/Events
European Hematology Association to hold a conference »

23rd Congress of the EHA…

XLRN

Acceleron

$36.04

-0.08 (-0.22%)

ARQL

ArQule

$5.00

-0.31 (-5.84%)

EPZM

Epizyme

$15.00

-0.85 (-5.36%)

KPTI

Karyopharm

$18.65

0.6 (3.32%)

APLS

Apellis

$22.34

0.26 (1.18%)

BLUE

Bluebird Bio

$182.75

-13.95 (-7.09%)

TGTX

TG Therapeutics

$13.75

-0.05 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

ELY

Callaway Golf

$20.36

0.135 (0.67%)

, GOLF

Acushnet Holdings

$25.00

0.17 (0.68%)

10:07
06/16/18
06/16
10:07
06/16/18
10:07
Periodicals
Despite hopeful signs, golf business may not be has healthy, Barron's says »

There are hopeful signs…

ELY

Callaway Golf

$20.36

0.135 (0.67%)

GOLF

Acushnet Holdings

$25.00

0.17 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.